Quince Therapeutics Investor Relations Material

Quince Therapeutics Inc is a U.S.-based biopharmaceutical company focused on the development and commercialization of targeted therapeutics for debilitating and rare diseases. The company’s pipeline includes treatments designed to improve drug delivery and tissue targeting for enhanced efficacy and safety. Quince Therapeutics leverages proprietary platforms and collaborates with partners to advance its clinical and preclinical programs. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.